Authors
Latest:
Oncology Drug Crash Course: Tucatinib and Trastuzumab for HER2+ CRCTucatinib was first approved by the FDA for the treatment of patients with HER2-positive advanced unresectable or metastatic breast cancer in combination with trastuzumab and capecitabine on April 17, 2020.
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
T-Cell Engagers Take Center Stage in Large B-Cell LymphomaBispecific antibodies that engage T cells are an effective treatment modality in relapsed/refractory disease and are an important new treatment for relapsed large B-cell lymphoma.
Latest:
Opinion: Now Is the Time to Optimize Electronic Health Record SystemsBuying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.
Latest:
Closing Reflection: A Journey of Understanding and ResiliencePanelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease management and improve quality of life while identifying opportunities to strengthen provider communication and access to resources.
Latest:
Kristin Daly on the Difference Between Somatic and Germline Variants in Precision OncologyKristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.
Latest:
Cleveland Clinic Opens New Cancer Center in Abu DhabiThe state-of-the-art facility represents the organization’s vision of global cancer care
Latest:
Oncology Drug Crash Course: Pirtobrutinib (Jaypirca)Sharon Kauffman, PhD, RN, CNE, NPD-BC, OCN, provides an in-depth look at pirtobrutinib in a downloadable reference sheet.
Latest:
Innovative Program Reduces Nurse Turnover and Fosters DevelopmentThe US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.
Latest:
COVID-19 and the Rise of Texting in Health CareThe last thing patients want is to be put on hold or interrupted by calls at work.
Latest:
How Social Media Helps AYA Patients With Cancer Find SupportThe rise of social media platforms has helped foster a community for adolescent and young adult patients with cancer.
Latest:
Informing Patients With Cancer About the Potential Impact of Immunotherapy on PregnancyAn expert explores the complexities of immunotherapy during pregnancy, highlighting risks to the fetus and the crucial role of oncology nurses in patient education and management.
Latest:
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast CancerKara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Latest:
T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer MutationsT-DXd led to an ORR of 59.4% vs 33.9% with chemo, regardless of biomarker status, in HR+, HER2-low metastatic breast cancer, per DESTINY-Breast06.
Latest:
Improved PFS Outcomes With Elacestrant Correlate With CDK4/6 Duration in ER+/HER2– Metastatic Breast CancerLonger duration of CDK4/6 inhibitor prior to treatment with elacestrant correlated with progression-free survival (PFS) improvements in patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer vs standard-of-care options.
Latest:
Patient Education Is Key to Improve Patient Adherence to Cancer TreatmentJessie Desir, PhD, RN, AMB-BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast cancer.
Latest:
Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse EventsMeredith Cummings BSN, RN, OCN, highlights her research on machine learning and its potential application in optimizing symptom management.
Latest:
Newly Approved Tebentafusp Requires Up-Front Active Toxicity Management in MelanomaTebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.
Latest:
Cardiotoxicities in Oncology Necessitate Nurse VigilanceThe intersection of cardiology and oncology is greater than nurses and providers may assume, explained 2 experts.
Latest:
Eric Zack on Disseminated Intravascular Coagulation Prevention and ManagementEric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
Latest:
Hospice Professionals Use Mind, Body, and Movement Meditation to Reduce StressA program evaluated at Michigan State University has shown that meditation helps combat burnout and promote well-being among health care workers, particularly in hospice settings.
Latest:
Oncology Nurses Are Uniquely Qualified to Meet the Needs of Patients With Lung CancerAs with all patients with cancer, providing care for those with lung cancer involves both physiological and psychological aspects.
Latest:
Cancer Medication Adherence in the Latinx/Hispanic CommunityUnderstanding psychosocial implications, barriers, risks, and impacts.
Latest:
Managing Chemo-Induced Peripheral Neuropathy in Breast CancerLa-Urshalar Brock, FNP-BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Latest:
Health Care Professionals Can Fight Burnout Through Their Diet“This is a holistic, functional and integrative approach to your mental well-being. So, you start small, and you build up on that. It is not an overnight fix; it is a slow and steady progress.”
Latest:
Nursing Education Can Be a Lifelong Marathon. Are You Ready for the Race?Nursing education should be viewed as a long-course endeavor rather than a sprint.
Latest:
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical CannabisAlyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Latest:
Bring A Nuanced Approach to Venous Thromboembolism ManagementUnderstanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Latest:
Kellie Zeichner Speaks to the Power of Standardized Monitoring Procedures for Patients With Rare TumorsKellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Latest:
Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.
